Matthew D Vera

Title: The Innovative Contributions of Matthew D Vera

Introduction

Matthew D Vera is a notable inventor based in Collegeville, PA, who has made significant contributions to the field of pharmaceuticals. With a total of five patents to his name, Vera has focused on developing innovative solutions for cancer treatment.

Latest Patents

One of Vera's latest patents is titled "Prodrugs of riluzole and their method of use." This pharmaceutical composition includes substituted riluzole prodrugs that are useful for treating various cancers, including melanoma, breast cancer, brain cancer, and prostate cancer. These prodrugs are designed to enhance stability against hepatic metabolism and are delivered into systemic circulation through oral administration. Once in the plasma, they are cleaved to release riluzole via either an enzymatic or general biophysical release process.

Career Highlights

Throughout his career, Matthew D Vera has worked with prominent organizations, including Biohaven Pharmaceutical Holding Company Limited and Rutgers, the State University of New Jersey. His work has focused on advancing pharmaceutical technologies that can improve patient outcomes in cancer treatment.

Collaborations

Vera has collaborated with notable colleagues such as Garry Robert Smith and Allen B Reitz, contributing to the development of innovative pharmaceutical solutions.

Conclusion

Matthew D Vera's work in the field of pharmaceuticals, particularly in the development of riluzole prodrugs, showcases his commitment to advancing cancer treatment. His contributions are significant and reflect his dedication to innovation in medicine.